| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/09/2000 | CA2340975A1 Synthetic tear fluid |
| 03/09/2000 | CA2340648A1 Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers or covering structures |
| 03/09/2000 | CA2340617A1 Genes associated with neurotransmitter processing |
| 03/09/2000 | CA2340596A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 03/09/2000 | CA2340592A1 Phelix: a testis-specific protein expressed in cancer |
| 03/09/2000 | CA2340206A1 Use of anti-pressor agents for vascular remodeling in genital dysfunction |
| 03/09/2000 | CA2339947A1 Method of mitigating the adverse effects of interleukin-2 |
| 03/09/2000 | CA2339823A1 Inherently antimicrobial quaternary amine hydrogel wound dressings |
| 03/09/2000 | CA2339664A1 Thieno{2,3,-d}pyrimidinedione derivatives and their use as immunosuppressants |
| 03/09/2000 | CA2339539A1 Modulating multiple lineage kinase proteins |
| 03/09/2000 | CA2339189A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| 03/09/2000 | CA2339145A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use |
| 03/09/2000 | CA2339140A1 Method of treating neurodegenerative diseases |
| 03/09/2000 | CA2249657A1 Novel compounds |
| 03/08/2000 | EP0984068A2 Sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents |
| 03/08/2000 | EP0984067A2 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
| 03/08/2000 | EP0984013A2 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1, 3-oxathiolane |
| 03/08/2000 | EP0984012A2 Nitric oxide releasing oxindole prodrugs with analgesic and anti-inflammatory properties |
| 03/08/2000 | EP0984008A2 Nitrosation process |
| 03/08/2000 | EP0984004A2 Trisubstituted-piperidinyl-N-alkylcarboxylates as opioid antagonists |
| 03/08/2000 | EP0984001A1 Compounds |
| 03/08/2000 | EP0983995A2 Pharmaceutically-active dimethyl-(3-aryl-but-3-enyl)-amine compounds |
| 03/08/2000 | EP0983994A2 Pharmaceutically-active dimethyl-(3-aryl-but-3-enyl)-amine compounds |
| 03/08/2000 | EP0983992A2 Compounds having selectivity for retinoid x receptors |
| 03/08/2000 | EP0983991A2 Compounds having selectivity for retinoid x receptors |
| 03/08/2000 | EP0983768A1 Medicinal composition for prevention or treatment of hepatopathy |
| 03/08/2000 | EP0983765A1 Preventives or remedies for diseases in association with vascular functional anomaly relating to insulin resistance |
| 03/08/2000 | EP0983764A1 Preventives for ischemic heart diseases |
| 03/08/2000 | EP0983763A1 Preventives for reconstriction |
| 03/08/2000 | EP0983726A1 Amino acid-trehalose composition |
| 03/08/2000 | EP0983360A1 Smad7 and uses thereof |
| 03/08/2000 | EP0983352A1 Prostate specific regulatory nucleic acid sequences and transgenic non-human animals expressing prostate specific antigen |
| 03/08/2000 | EP0983304A1 Dermatan disulfate, an inhibitor of thrombin generation and complement activation |
| 03/08/2000 | EP0983295A2 4-aza-steroids substituted in one or more of positions 7, 11 and 15 or with an unsaturated 14(15)-double bond as inhibitors of testosterone-5-alpha-reductase |
| 03/08/2000 | EP0983294A1 B-ring estratriene diol sulphates |
| 03/08/2000 | EP0983291A1 Carbamate-derivatized nucleosides and oligonucleosides |
| 03/08/2000 | EP0983287A1 Novel glycosylated ginkgolide derivatives, their application as medicines and pharmaceutical compositions |
| 03/08/2000 | EP0983286A1 Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
| 03/08/2000 | EP0983283A1 Nitric oxide carriers based on polyazamacrocycle complexes |
| 03/08/2000 | EP0983275A1 Novel triptolide derivatives useful in the treatment of autoimmune diseases |
| 03/08/2000 | EP0983273A1 Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents |
| 03/08/2000 | EP0983272A1 A new class of benzoporphyrin derivative photoactive compounds |
| 03/08/2000 | EP0983271A1 Carbocyclic nucleoside hemisulfate and its use in treating viral infections |
| 03/08/2000 | EP0983270A1 PROCESS FOR PREPARING 6-$i(O)-MONOESTERS OF CASTANOSPERMINE |
| 03/08/2000 | EP0983268A1 Amidine derivatives as inhibitors of nitric oxide synthase |
| 03/08/2000 | EP0983267A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 03/08/2000 | EP0983266A1 Compounds |
| 03/08/2000 | EP0983265A1 Endothelin receptor antagonists |
| 03/08/2000 | EP0983263A1 Novel benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them |
| 03/08/2000 | EP0983262A1 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists |
| 03/08/2000 | EP0983260A2 3(5)-HETEROARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS |
| 03/08/2000 | EP0983259A1 Tocopherol esters and their cosmetic and pharmaceutical uses |
| 03/08/2000 | EP0983258A1 N-hydroxy 4-sulfonyl butanamide compounds |
| 03/08/2000 | EP0983257A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| 03/08/2000 | EP0983256A1 Novel triptolide derivatives useful in the treatment of autoimmune diseases |
| 03/08/2000 | EP0983251A1 Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof |
| 03/08/2000 | EP0983249A1 Processes and intermediates for preparing substituted indazole derivatives |
| 03/08/2000 | EP0983248A1 Analogs of duocarmycin and cc-1065 |
| 03/08/2000 | EP0983245A1 Substituted tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors |
| 03/08/2000 | EP0983244A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors |
| 03/08/2000 | EP0983243A1 Novel quinoline- and naphthalenecarboxamides, pharmaceutical compositions and methods of inhibiting calpain |
| 03/08/2000 | EP0983242A1 Method for producing particles of pyrithione salts |
| 03/08/2000 | EP0983241A1 Cyanoguanidines as cell proliferation inhibitors |
| 03/08/2000 | EP0983235A2 Leukotriene b 4? derivatives, in particular oximo-ltb 4? antagonists |
| 03/08/2000 | EP0983234A1 Leukotriene b 4? derivatives, in particular 7-methylcyclohexyl-ltb 4? antagonists |
| 03/08/2000 | EP0983229A1 Metalloproteinase inhibitors |
| 03/08/2000 | EP0983228A1 Protease inhibitors |
| 03/08/2000 | EP0983226A1 New nitromethyl ketones, process for preparing them and compositions containing them |
| 03/08/2000 | EP0983222A1 Pharmaceutical agents for the treatment of cerebral amyloidosis |
| 03/08/2000 | EP0983221A1 Cyclohexanediol derivatives |
| 03/08/2000 | EP0983073A1 Ophthalmic compositions containing a divalent salt and a non steroidal anti-inflammatory drugs as a precipitate |
| 03/08/2000 | EP0983072A1 Fructan containing composition for the prevention and treatment of colon cancer |
| 03/08/2000 | EP0983071A1 Use of hypothalamic inhibitory factor in the treatment of ischemic cardiac malfunction |
| 03/08/2000 | EP0983070A1 Prevention of ovarian cancer by administration of a vitamin d compound |
| 03/08/2000 | EP0983069A1 Use of taurolidine for treatment of leukemias |
| 03/08/2000 | EP0983068A1 THE USE OF 1,2,4-TRIAZOLO 1,5-c]PYRIMIDINE HETEROCYCLIC ANALOGUES FOR THE PREPARATION OF MEDICAMENTS USEFUL FOR THE TREATMENT OF CEREBROVASCULAR DISTURBANCES |
| 03/08/2000 | EP0983067A1 Benzimidazole pharmaceutical composition and process of preparation |
| 03/08/2000 | EP0983066A1 Pharmaceutical composition comprising alkanoyl l-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism |
| 03/08/2000 | EP0983065A1 Gastric-retained pharmaceutical composition |
| 03/08/2000 | EP0983064A1 PYRROLES AS sPLA2 INHIBITORS |
| 03/08/2000 | EP0983063A1 Pharmaceutical composition containing uscharidin or its analogues |
| 03/08/2000 | EP0983062A1 Method for increasing the concentration of ascorbic acid in brain tissues of a subject |
| 03/08/2000 | EP0983059A1 Process for making flurbiprofen lozenges |
| 03/08/2000 | EP0983058A1 Medicinal aerosol products |
| 03/08/2000 | EP0983055A1 Composition comprising an amino acid n-undecylenoyl; application in cosmetics |
| 03/08/2000 | EP0983054A1 Hair growth compositions and uses |
| 03/08/2000 | EP0983037A1 Antifungal nail lacquer and method using same |
| 03/08/2000 | EP0982991A1 Beta lactams as antiproliferative agents |
| 03/08/2000 | EP0982990A1 Stable liquid mineral ascorbate compositions and methods of manufacture and use |
| 03/08/2000 | EP0982988A1 Substantially pure zonulin, a physiological modulator of mammalian tight junctions |
| 03/08/2000 | EP0861054A4 Photochemistry for the preparation of biologic grafts-allografts and xenografts |
| 03/08/2000 | EP0835125A4 Cd4-derived peptides that inhibit immune responses |
| 03/08/2000 | EP0820275A4 Cosmetic melanins |
| 03/08/2000 | EP0784623B1 Naphthyridine derivatives |
| 03/08/2000 | EP0770082B1 Dioxo-thiopyrano-pyridine carboxylic acid derivatives and their use as medicaments |
| 03/08/2000 | EP0696287B1 Ureido derivatives of naphthalenephosphonic acids and process for their preparation |
| 03/08/2000 | EP0591355B1 Porphycene compounds for photodynamic therapy |
| 03/08/2000 | CN1246865A Antigestagenic steroids with fluorinated 17 'alpha'-alkyl chair |
| 03/08/2000 | CN1246862A Epothilone analogs |
| 03/08/2000 | CN1246861A Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds |